US 7109172
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61PA61P1/16A61P31/12
Quick answer
US patent 7109172 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/16, A61P31/12, A61P31/14, A61P43/00